Peptide News
transmembrane proteins as therapeutic agents encounter challenges like limited expression, in vitro insolubility, unstable purification processes, and the complexities of maintaining their native conformation.
GenScript offers a solution by advocating for the use of mRNA as a viable antigen format for developing antibodies targeting these membrane proteins. This poster provides insight into our experiences with this approach, showcasing its potential in addressing the current obstacles in this field.